+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024

  • ID: 4761607
  • Report
  • Region: Global
  • 147 Pages
  • Markets and Markets
1 of 6
Global Infusion Pump Software Market is Projected to Reach 1,044 Million by 2024 from USD 742 Million in 2019 at a CAGR Of 7.1%

FEATURED COMPANIES

  • Fresenius Kabi
  • Medtronic Plc (Medtronic)
  • Micrel Medical Devices
  • Moog Inc. (Moog)
  • Terumo Corporation
  • Ypsomed AG (Ypsomed)
  • MORE

"The infusion pump software market is projected to grow at a CAGR of 7.1% during the forecast period."

The global infusion pump software market is projected to reach 1,044 million by 2024 from USD 742 million in 2019 at a CAGR of 7.1%. Growth in the infusion pump software market can be attributed to factors such as increasing incidence of chronic diseases, along with rapid growth in the geriatric population, growing number of surgical procedures performed, rising demand for ambulatory and home care infusion pumps, and technological developments. However, frequent product recalls of infusion pumps may restrain the market to a certain extent.

"The DERS segment is expected to hold the largest market share during the forecast period."

On the basis of type, the global infusion pump software market has been segmented into Dose error reduction software (DERS), clinical workflow software, interoperability software and other software. The DERS segment is expected to hold the largest market share during the forecast period. DERS is offered as a part of the drug library incorporated in the infusion pump. This software aids in preventing incorrect dosage of medicine by alerting the clinician via alarm. Subsequently, increasing number of reported medication errors using infusion pumps is a major factor boosting this market growth.

"The insulin infusion segment is expected to grow at the highest rate during the forecast period."

On the basis of indication, the infusion pump software market is segmented into general infusion, pain & anesthesia management, insulin infusion, chemotherapy, enteral infusion, and others. The general infusion segment is expected to take the largest share of this market. The high growth of this segment can be attributed to factors such as the ease and safety offered by infusion pumps software for delivery of medication.

"The Home care settings segment is expected to grow at the highest rate during the forecast period."

On the basis of end user, the infusion pump software market is segmented into hospitals, ambulatory care settings, home care settings, and academic & research institutes. The home care settings segment is expected to grow at the highest rate during the forecast period. The high growth of this segment can be attributed to factors such as increasing preference for treatment at one’s convenience and the advantage of home infusion being highly cost effective.

"The Asia Pacific infusion pump software market is expected to grow at the highest rate during the forecast period."

Geographically, the infusion pump software market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest rate during the forecast period. The high growth in this region can be attributed to the a large population pool, increasing aging population, growing incidences of chronic diseases, increased awareness and accessibility of advanced healthcare facilities, and rising healthcare spending.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 55%, Tier 2 - 20%, and Tier 3 - 25%
  • By Designation: C-level - 35%, Director-level - 25%, and Others - 40%
  • By Region: North America - 20%, Europe - 25%, APAC - 40%, and RoW - 15%

The major players in the market include BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), Terumo Medical (Japan), Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).

Research Coverage

This report studies the infusion pump software market based on type, end user, indication, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the infusion pump software market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Fresenius Kabi
  • Medtronic Plc (Medtronic)
  • Micrel Medical Devices
  • Moog Inc. (Moog)
  • Terumo Corporation
  • Ypsomed AG (Ypsomed)
  • MORE

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
           2.1.3 Primary Sources
                    2.1.3.1 Key Insights From Primary Sources
                    2.1.3.2 Market Size Estimation Methodology
           2.1.4 Market Data Estimation and Triangulation
    2.2 Assumptions

3 Executive Summary

4 Premium Insights
    4.1 Infusion Pump Software Market Overview
    4.2 Geographic Analysis: European Infusion Pump Software Market Share, By Type, 2019
    4.3 Infusion Pump Software Market Share, By Indication, 2019 vs. 2024
    4.4 Infusion Pump Software Market Share, By Type, 2019 vs. 2024
    4.5 Infusion Pump Software Market Share, By End User, 2019 vs. 2024
    4.6 Infusion Pump Software Market: Geographical Snapshot

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Increasing Incidence of Chronic Diseases and Rapid Growth in Geriatric Population
                    5.2.1.2 Growing Number of Surgical Procedures Performed
                    5.2.1.3 Rising Demand for Ambulatory and Home Care Infusion Pumps
                    5.2.1.4 Technological Developments
           5.2.2 Market Restraints
                    5.2.2.1 Frequent Product Recalls of Infusion Pumps
           5.2.3 Market Opportunities
                    5.2.3.1 Untapped Emerging Markets
                    5.2.3.2 Growing Adoption of Specialty Infusion Systems
           5.2.4 Challenges
                    5.2.4.1 Increasing Incidence of Medication Errors and Lack of Wireless Connectivity in Most Hospitals

6 Infusion Pump Software Market, By Type
    6.1 Introduction
    6.2 Dose Error Reduction Software (DERS)
           6.2.1 Increasing Incidence of Medication Errors is Driving the Demand for DERS in Infusion Pumps
    6.3 Clinical Workflow Software
           6.3.1 Clinical Workflow Software Enables Automation of the Entire Process of A Patient’s Assessment and Treatment
    6.4 Interoperability Software
           6.4.1 Interoperability Software Helps in Reducing Manual Programming Errors
    6.5 Others

7 Infusion Pump Software Market, By Indication
    7.1 Introduction
    7.2 General Infusion
           7.2.1 Availability of Safer and Efficient Infusion Pumps to Propel the Market for General Infusion
    7.3 Pain & Anesthesia Management
           7.3.1 High Incidence of Chronic Pain Will Drive the Market for Pain Management
    7.4 Insulin Infusion
           7.4.1 Significant Increase in the Global Prevalence of Diabetes Will Drive Market Growth
    7.5 Chemotherapy
           7.5.1 Demand for Controlled and Targeted Delivery of Medication to Drive the Chemotherapy Market
    7.6 Enteral Infusion
           7.6.1 Infusion Pumps Facilitate Continuous and Controlled Parenteral Flow
    7.7 Other Indications

8 Infusion Pump Software Market, By End User
    8.1 Introduction
    8.2 Hospitals
           8.2.1 Hospitals Dominate the Infusion Pump Software Market, By End User
    8.3 Ambulatory Care Settings
           8.3.1 Need to Reduce Healthcare Expenditure has Boosted the Preference for Ambulatory Care
    8.4 Home Care Settings
           8.4.1 Rising Acceptance and Cost-Efficiency of Home Care Products Have Driven their Use
    8.5 Academic & Research Institutes
           8.5.1 Rising Drug Discovery Activity and Incidence of Medication Errors is Driving Market Growth

9 Infusion Pump Software Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 US is the Largest Market for Infusion Pump Software
           9.2.2 Canada
                    9.2.2.1 Favorable Reimbursement Scenario for Infusion Pumps to Propel the Market in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Germany is the Fastest-Growing Market for Infusion Pump Software in Europe
           9.3.2 France
                    9.3.2.1 The Healthcare System in France is Among the Best in the World
           9.3.3 UK
                    9.3.3.1 High Number of Medication Errors in the UK to Drive Market Growth
           9.3.4 RoE
    9.4 APAC
           9.4.1 China
                    9.4.1.1 Growing Investments in Healthcare Infrastructure to Support Market Growth
           9.4.2 Japan
                    9.4.2.1 Rapid Growth in the Geriatric Population and the Rising Prevalence of Age-Related Illnesses to Drive Market Growth
           9.4.3 India
                    9.4.3.1 High Prevalence of Lifestyle Diseases to Drive the Market for Infusion Pump Software
           9.4.4 RoAPAC
    9.5 Rest of the World

10 Competitive Landscape
     10.1 Overview
             10.1.1 Market Ranking of Players, 2018
     10.2 Competitive Leadership Mapping
             10.2.1 Visionary Leaders
             10.2.2 Innovators
             10.2.3 Dynamic Differentiators
             10.2.4 Emerging Companies
     10.3 Competitive Scenario
             10.3.1 Product Launches
             10.3.2 Expansions
             10.3.3 Partnerships, Agreements, and Collaborations
             10.3.4 Acquisitions

11 Company Profiles
     11.1 Becton, Dickinson and Company (BD)
     11.2 B. Braun Melsungen AG (B. Braun)
     11.3 Baxter International Inc. (Baxter)
     11.4 Fresenius Kabi
     11.5 ICU Medical, Inc. (ICU Medical)
     11.6 Medtronic Plc (Medtronic)
     11.7 Moog Inc. (Moog)
     11.8 Smiths Medical (A Division of Smiths Group Plc)
     11.9 Terumo Corporation
     11.10 Roche Diagnostics (A Division of F. Hoffmann- La Roche Ltd.)
     11.11 Ypsomed AG (Ypsomed)
     11.12 Micrel Medical Devices

List of Tables
Table 1 Indicative List of Product Recalls for Infusion Pump Software (2015-2017)
Table 2 Infusion Pump Software Market, By Type, 2017-2024 (USD Million)
Table 3 Market, By Region, 2017-2024 (USD Million)
Table 4 Market for DER's, By Region, 2017-2024 (USD Million)
Table 5 Infusion Pump Clinical Workflow Software Market, By Region, 2017-2024 (USD Million)
Table 6 Infusion Pump Interoperability Software Market, By Region, 2017-2024 (USD Million)
Table 7 Other Infusion Pump Software Market, By Region, 2017-2024 (USD Million)
Table 8 Market, By Indication, 2017-2024 (USD Million)
Table 9 Market for General Infusion, By Region, 2017-2024 (USD Million)
Table 10 Market for Pain & Anesthesia Management, By Region, 2017-2024 (USD Million)
Table 11 Market for Insulin Infusion, By Region, 2017-2024 (USD Million)
Table 12 Market for Chemotherapy, By Region, 2017-2024 (USD Million)
Table 13 Market for Enteral Infusion, By Region,2017-2024 (USD Million)
Table 14 Market for Other Indications, By Region, 2017-2024 (USD Million)
Table 15 Market, By End User, 2017-2024 (USD Million)
Table 16 Market for Hospitals, By Region, 2017-2024 (USD Million)
Table 17 Market for Ambulatory Care Settings, By Region, 2017-2024 (USD Million)
Table 18 Market for Home Care Settings, By Region, 2017-2024 (USD Million)
Table 19 Market for Academic & Research Institutes, By Region, 2017-2024 (USD Million)
Table 20 Market, By Region, 2017-2024 (USD Million)
Table 21 North America: Market, By Country, 2017-2024 (USD Million)
Table 22 North America: Market, By Type, 2017-2024 (USD Million)
Table 23 North America: Market, By Indication, 2017-2024 (USD Million)
Table 24 North America: Market, By End User, 2017-2024 (USD Million)
Table 25 US: Market, By Type, 2017-2024 (USD Million)
Table 26 US: Market, By Indication, 2017-2024 (USD Million)
Table 27 US: Market, By End User, 2017-2024 (USD Million)
Table 28 Canada: Market, By Type, 2017-2024 (USD Million)
Table 29 Canada: Market, By Indication, 2017-2024 (USD Million)
Table 30 Canada: Market, By End User, 2017-2024 (USD Million)
Table 31 Europe: Market, By Country, 2017-2024 (USD Million)
Table 32 Europe: Market, By Type, 2017-2024 (USD Million)
Table 33 Europe: Market, By Indication, 2017-2024 (USD Million)
Table 34 Europe: Market, By End User, 2017-2024 (USD Million)
Table 35 Germany: Market, By Type, 2017-2024 (USD Million)
Table 36 Germany: Market, By Indication, 2017-2024 (USD Million)
Table 37 Germany: Market, By End User, 2017-2024 (USD Million)
Table 38 France: Market, By Type, 2017-2024 (USD Million)
Table 39 France: Market, By Indication, 2017-2024 (USD Million)
Table 40 France: Market, By End User, 2017-2024 (USD Million)
Table 41 UK: Market, By Type, 2017-2024 (USD Million)
Table 42 UK: Market, By Indication, 2017-2024 (USD Million)
Table 43 UK: Market, By End User, 2017-2024 (USD Million)
Table 44 RoE: Market, By Type, 2017-2024 (USD Million)
Table 45 RoE: Market, By Indication, 2017-2024 (USD Million)
Table 46 RoE: Market, By End User, 2017-2024 (USD Million)
Table 47 Asia Pacific Market, By Country, 2017-2024 (USD Million)
Table 48 Asia Pacific: Market, By Type, 2017-2024 (USD Million)
Table 49 Asia Pacific: Market, By Indication, 2017-2024 (USD Million)
Table 50 Asia Pacific: Market, By End User, 2017-2024 (USD Million)
Table 51 China: Market, By Type, 2017-2024 (USD Million)
Table 52 China: Market, By Indication, 2017-2024 (USD Million)
Table 53 China: Market, By End User, 2017-2024 (USD Million)
Table 54 Japan: Market, By Type, 2017-2024 (USD Million)
Table 55 Japan: Market, By Indication, 2017-2024 (USD Million)
Table 56 Japan: Market, By End User, 2017-2024 (USD Million)
Table 57 India: Market, By Type, 2017-2024 (USD Million)
Table 58 India: Market, By Indication, 2017-2024 (USD Million)
Table 59 India: Market, By End User, 2017-2024 (USD Million)
Table 60 RoAPAC : Market, By Type, 2017-2024 (USD Million)
Table 61 RoAPAC : Market, By Indication, 2017-2024 (USD Million)
Table 62 RoAPAC : Market, By End User, 2017-2024 (USD Million)
Table 63 RoW: Market, By Type, 2017-2024 (USD Million)
Table 64 RoW: Market, By Indication, 2017-2024 (USD Million)
Table 65 RoW: Market, By End User, 2017-2024 (USD Million)
Table 66 Product Launches and Approvals
Table 67 Expansions
Table 68 Partnerships, Agreements, and Collaborations
Table 69 Acquisitions

List of Figures
Figure 1 Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market : Bottom-Up Approach
Figure 5 Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Type, 2019 vs. 2024 (USD Million)
Figure 8 Market Share, By Indication, 2019 vs. 2024 (USD Million)
Figure 9 Market Share, By End User, 2018
Figure 10 Geographical Snapshot of the Infusion Pump Software Market
Figure 11 Increasing Incidence of Chronic Diseases to Drive the Growth of the Market During the Forecast Period
Figure 12 Germany to Account for the Largest Share in the European Infusion Pump Software Market in 2019
Figure 13 General Infusion Segment to Dominate the Infusion Pump Software Market During the Forecast Period
Figure 14 DERS Segment to Account for the Dominant Share of the Market in 2019
Figure 15 Hospitals to Dominate the Infusion Pump Software Market in 2024
Figure 16 APAC to Register the Highest CAGR During the Forecast Period
Figure 17 Infusion Pump Software Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Global Cancer Incidence, 2008-2030
Figure 19 Estimated Diabetic Population, By Region, 2015 vs. 2040
Figure 20 DERS Segment to Witness the Highest Growth in the Infusion Pump Software Market During the Forecast Period
Figure 21 Insulin Infusion Segment to Grow at the Highest CAGR During the Forecast Period
Figure 22 Hospitals to Account for the Largest Share in the Infusion Pump Software Market in 2018
Figure 23 North America Accounted for the Largest Share of the Infusion Pump Software Market in 2018
Figure 24 North America: Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 APAC: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Key Developments in the Infusion Pump Software Market Between 2016 and 2018
Figure 29 Market Ranking, By Key Player
Figure 30 Market, Competitive Leadership Mapping, 2018
Figure 31 Becton, Dickinson and Company: Company Snapshot (2018)
Figure 32 B. Braun: Company Snapshot (2017)
Figure 33 Baxter: Company Snapshot (2017)
Figure 34 Fresenius Kabi: Company Snapshot (2017)
Figure 35 ICU Medical: Company Snapshot (2017)
Figure 36 Medtronic: Company Snapshot (2017)
Figure 37 Moog: Company Snapshot (2018)
Figure 38 Smiths Medical: Company Snapshot (2018)
Figure 39 Terumo Corporation: General Hospital Company Segment Snapshot (2017)
Figure 40 Roche: Company Snapshot (2018)
Figure 41 Ypsomed: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • B. Braun Melsungen AG (B. Braun)
  • Baxter International Inc. (Baxter)
  • Becton, Dickinson and Company (BD)
  • Fresenius Kabi
  • ICU Medical, Inc. (ICU Medical)
  • Medtronic Plc (Medtronic)
  • Micrel Medical Devices
  • Moog Inc. (Moog)
  • Roche Diagnostics (A Division of F. Hoffmann- La Roche Ltd.)
  • Smiths Medical (A Division of Smiths Group Plc)
  • Terumo Corporation
  • Ypsomed AG (Ypsomed)
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4761607
Adroll
adroll